We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FTAL:TASEFattal Holdings (1998) Ltd. Analysis

Data as of 2026-07-08 - not real-time

ILA 74,290.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Fattal Holdings is trading just below its short‑term moving average, with the price hugging the 20‑day SMA and comfortably above the 200‑day SMA, suggesting a modest technical support level. The RSI sits in the upper‑mid range, indicating momentum but not yet overbought, while the MACD histogram is positive, delivering a bullish signal despite the MACD line remaining in negative territory. Overall market direction is neutral, and volume has been stable, yet the stock has exhibited elevated recent volatility, reflecting the sensitivity of the lodging sector to travel demand fluctuations. The company carries a very high leverage profile, with debt far outweighing equity, and it is reporting negative earnings per share and slim profit margins, leaving little room for dividend sustainability. Cash generation from operations is modest and free cash flow is negative, underscoring cash‑flow pressure. The price‑to‑book multiple is above two, and the price‑to‑sales ratio suggests the market is assigning a premium despite weak fundamentals.
Given the combination of high leverage, negative profitability, and a valuation that appears stretched, the stock leans toward being overvalued and aligns more with a value‑oriented assessment rather than a growth story. The risk landscape is tilted higher due to sector cyclicality, regional exposure, and limited liquidity, while the low beta tempers systematic market risk. Consequently, the outlook favors caution, with short‑term positioning leaning toward a hold, and medium‑ to long‑term recommendations shifting toward a sell stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near short‑term moving average
  • positive MACD histogram
  • stable volume

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • high debt‑to‑equity ratio
  • negative earnings and cash flow
  • elevated sector cyclicality

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • overvalued pricing relative to fundamentals
  • ongoing leverage concerns
  • lack of dividend income

Key Metrics & Analysis

Financial Health

Revenue Growth-4.70%
Profit Margin-0.10%
ROE-0.04%
ROA2.25%
Debt/Equity531.14
P/B Ratio2.9
Op. Cash FlowILA1.0B
Free Cash FlowILA-529889504

Technical Analysis

TrendNeutral
RSI58.5
SupportILA 68,360.00
ResistanceILA 80,380.00
MA 20ILA 74,132.50
MA 50ILA 75,968.60
MA 200ILA 65,109.60
MACDBullish
VolumeStable
Fear & Greed Index92.63

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.58
Volatility37.30%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.